Corporate News     19-Sep-22
Delhi HC allows Natco Pharma to launch Chlorantraniliprole and its formulations
Natco Pharma today received Order from Hon'ble High Court of Delhi stating that NATCO is allowed to launch Chlorantraniliprole (CTPR) and its formulations, through its non-infringing process.

NATCO is the 1st Company in India to have received its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC) recorded in its Minutes of the 425th Meeting held on 25 January 2021, for indigenous manufacture of Chlorantraniliprole (CTPR) Technical 93.00% w/w min. under Section 9(3). CTPR technical is formulated into broad spectrum insecticides used across wide range of crops for pest management.

NATCO estimates the current market size of CTPR containing products in India to be over Rs 2000 crore. The Company plans to launch its products very shortly.

Previous News
  Natco Pharma fixes record date for interim dividend
 ( Market Beat - Reports 09-Aug-23   15:22 )
  Natco Pharma consolidated net profit declines 22.51% in the December 2022 quarter
 ( Results - Announcements 09-Feb-23   14:54 )
  Natco Pharma to conduct board meeting
 ( Corporate News - 01-Nov-22   12:10 )
  Natco Pharma Ltd spurts 0.09%, gains for fifth straight session
 ( Hot Pursuit - 25-Jul-23   13:00 )
  Natco Pharma consolidated net profit declines 67.84% in the September 2021 quarter
 ( Results - Announcements 11-Nov-21   15:55 )
  Natco Pharma
 ( Results - Analysis 11-Nov-22   16:31 )
  Natco Pharma Ltd spurts 1.44%, gains for five straight sessions
 ( Hot Pursuit - 09-Aug-23   13:00 )
  Natco Pharma gets USFDA nod for myeloma cancer drug
 ( Hot Pursuit - 13-Nov-20   11:23 )
  Natco Pharma to table results
 ( Corporate News - 01-Feb-23   16:51 )
  Natco Pharma launches two CTPR pesticide products
 ( Corporate News - 04-Oct-22   12:55 )
  Natco launches first generic version of Nexavar® (Sorafenib) Tablets in US market
 ( Corporate News - 01-Jun-22   09:57 )
Other Stories
  CG Power & Industrial Solutions to acquire radio frequency components biz of Renesas
  05-Oct-24   10:30
  MMP Industries to convene board meeting
  05-Oct-24   10:23
  Mahindra & Mahindra Financial Serv. to discuss results
  05-Oct-24   10:23
  Ambey Laboratories to hold board meeting
  05-Oct-24   10:23
  Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'
  05-Oct-24   10:21
  Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV
  05-Oct-24   10:19
  Just Dial announces board meeting date
  05-Oct-24   10:11
  L&T Finance schedules board meeting
  05-Oct-24   10:11
  Australian Premium Solar (India) announces board meeting date
  05-Oct-24   10:11
  Reliance Industrial InfraStructure declare Quarterly Result
  05-Oct-24   10:11
Back Top